[June 04, 2015]

Research and Markets: Global Cardiomyopathy Pipeline Review, H1 2015 - Analysis of 18 Pharmaceutical Companies & 28 Drug Profiles

Research and Markets (http://www.researchandmarkets.com/research/zll2jr/cardiomyopathy) has announced the addition of the "Cardiomyopathy - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Cardiomyopathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cardiomyopathy and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Deveopment

• Array BioPharma Inc.
• Beech Tree Labs, Inc.
• Bioheart, Inc.
• Celladon Corporation
• Gilead Sciences, Inc.
• Kasiak Research Pvt. Ltd.
• LG Life Sciences, Ltd.
• miRagen Therapeutics, Inc.
• MyoKardia, Inc.
• Neurimmune Holding AG
• Novartis AG
• Nyken BV
• Sanofi
• Shire Plc
• Stemedica Cell Technologies, Inc.
• Stempeutics Research Private Limited
• Torrent Pharmaceuticals Limited
• Vericel Corporation

Drug Profiles

• AdipoCell
• ARRY-797
• binimetinib
• CAP-1002
• Cyndacel-M
• Drug for Cardiomyopathy
• Drugs to Activate Nrf2 for Diabetic Cardiomyopathy
• Gene Therapy for Cardiomyopathy
• Gene therapy to Activate mSCF for Ischemic Cardiomyopathy
• Gene Therapy to Activate Smad7 for Hypertensive Cardiomyopathy and Kidney Fibrosis
• GLP-1
• GS-6615
• ixmyelocel-T
• JR-100
• LC-280126
• Mesenchymal Stem Cells
• MGN-9103
• Monoclonal Antibodies for Cardiovascular Diseases
• MYK-461
• NI-301
• NYK-1112
• perhexiline maleate
• Recombinant Protein to Antagonize Interleukin-1 Receptor for Cardiomyopathy and Ischemia Reperfusion Injury
• Refacell-DCM (News - Alert)
• SHP-627
• Small Molecule for Dilated Cardiomyopathy
• Stempeucel
• TRC-120038

For more information visit http://www.researchandmarkets.com/research/zll2jr/cardiomyopathy

View source version on businesswire.com: http://www.businesswire.com/news/home/20150604005988/en/

[ Back To TMCnet.com's Homepage ]